Water → HCID 57917366、化合物
反応式
[CH3:1][N:2]1[CH:6]=[C:5]([C:7]2[CH:8]=[CH:9][C:10]3[N:11]([C:13]([CH2:16][C:17]4[CH:18]=[CH:19][C:20]5[N:21]([C:23]([CH:26]=[CH2:27])=[CH:24][N:25]=5)[CH:22]=4)=[CH:14][N:15]=3)[N:12]=2)[CH:4]=[N:3]1.[OH2:28].[O-][Mn](=O)(=O)=O.[K+].[OH-:35].[Na+]>O1CCOCC1>[CH3:1][N:2]1[CH:6]=[C:5]([C:7]2[CH:8]=[CH:9][C:10]3[N:11]([C:13]([CH2:16][C:17]4[CH:18]=[CH:19][C:20]5[N:21]([C:23]([CH:26]([OH:35])[CH2:27][OH:28])=[CH:24][N:25]=5)[CH:22]=4)=[CH:14][N:15]=3)[N:12]=2)[CH:4]=[N:3]1参加物
実験手順
6-(1-Methyl-1H-pyrazol-4-yl)-3-(3-vinyl-imidazo[1,2-a]pyridin-6-ylmethyl)-imidazo[1,2-b]pyridazine (Example 299, 49 mg, 0.138 mmol) was dissolved in dioxane (0.69 mL) and water (0.69 mL) then KMnO4 (21.8 mg, 0.138 mmol) and 2.5 M NaOH solution (0.165 mL, 0.414 mmol) were added. The RM was stirred at rt for 3 h. It was then filtered through Celite and the solvent was removed. The residue was purified by preparative HPLC with acetonitrile and water (+0.1% TFA). The fractions were joined and were lyophilized. The residue was dissolved in MeOH and it was passed through an SPE cartridge of HCO3− to remove the TFA salt. The filtrate was evaporated and the residue was triturated with pentane. The precipitate was filtered off and dried to afford the title compound as a white solid (tR 0.3 min (conditions 2), MH+=390).
後処理
- filtrationIt was then filtered through Celite
- customthe solvent was removed
- customThe residue was purified by preparative HPLC with acetonitrile and water (+0.1% TFA)
- dissolutionThe residue was dissolved in MeOH
- customto remove the TFA salt
- customThe filtrate was evaporated
- customthe residue was triturated with pentane
- filtrationThe precipitate was filtered off
- customdried
出典と根拠
- ORDレコード
- ord-07c36265571f4936981bf13ddc80f4a7
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08822468B2
反応ノート
読み込み中…